Fulcrum Therapeutics Promotes Diego Cadavid, M.D., to Senior Vice President, Clinical Development

Cambridge, Mass., August 14, 2018 – Fulcrum Therapeutics, a company focused on discovering and developing small molecule therapies that unlock gene regulation to treat serious genetic diseases, today announced the promotion of Diego Cadavid, M.D., formerly Vice President, Clinical Development, to Senior Vice President, Clinical Development.

Read More